Potent and selective LXR inverse agonist (IC50
values are 43 and 214 nM for LXRβ
, respectively). Selectively inhibits liver LXR over peripheral LXR. Exhibits selectivity for LXR over a panel of 20 other nuclear receptors, including FXR. Reduces hepatic steatosis in obese mice.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A liver-selective LXR inverse agonist that suppresses hepatic steatosis.
Griffett et al.
ACS Chem.Biol., 2013;8:559